 Johan Van Hove
Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperglycinemia, Nonketotic | 9 | 2024 | 51 | 4.040 |
Why?
| | DNA, Mitochondrial | 6 | 2021 | 190 | 2.000 |
Why?
| | Mitochondrial Diseases | 7 | 2024 | 90 | 1.800 |
Why?
| | Epilepsy | 8 | 2022 | 323 | 1.790 |
Why?
| | Glycine | 5 | 2024 | 163 | 1.650 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2022 | 101 | 1.470 |
Why?
| | Cardiomyopathies | 3 | 2024 | 336 | 1.450 |
Why?
| | Mitochondrial Proteins | 5 | 2021 | 245 | 1.410 |
Why?
| | Mutation | 17 | 2024 | 3696 | 1.370 |
Why?
| | Acyl-CoA Dehydrogenases | 2 | 2024 | 11 | 1.110 |
Why?
| | Mitochondria | 6 | 2021 | 855 | 1.040 |
Why?
| | Pyridoxine | 6 | 2022 | 32 | 1.020 |
Why?
| | Bezafibrate | 1 | 2024 | 9 | 0.900 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 24 | 0.900 |
Why?
| | Acidosis, Lactic | 1 | 2024 | 45 | 0.880 |
Why?
| | Niacinamide | 1 | 2024 | 73 | 0.870 |
Why?
| | Alagille Syndrome | 1 | 2024 | 33 | 0.870 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 39 | 0.860 |
Why?
| | Infant | 26 | 2024 | 9001 | 0.830 |
Why?
| | Leukoencephalopathies | 2 | 2019 | 21 | 0.780 |
Why?
| | Corpus Callosum | 2 | 2019 | 66 | 0.770 |
Why?
| | Biliary Atresia | 1 | 2024 | 161 | 0.770 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 77 | 0.710 |
Why?
| | Lysine | 5 | 2022 | 285 | 0.710 |
Why?
| | Phenotype | 6 | 2024 | 3051 | 0.700 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 258 | 0.690 |
Why?
| | White Matter | 2 | 2019 | 134 | 0.690 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 38 | 0.650 |
Why?
| | Thalamus | 1 | 2019 | 85 | 0.630 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 398 | 0.620 |
Why?
| | Energy Metabolism | 3 | 2015 | 833 | 0.620 |
Why?
| | Diseases in Twins | 1 | 2019 | 176 | 0.610 |
Why?
| | Magnetic Resonance Imaging | 10 | 2020 | 3387 | 0.590 |
Why?
| | Arginine | 2 | 2020 | 260 | 0.590 |
Why?
| | Leigh Disease | 3 | 2015 | 19 | 0.550 |
Why?
| | Vitamin B Complex | 2 | 2015 | 41 | 0.550 |
Why?
| | Mutation, Missense | 2 | 2016 | 315 | 0.540 |
Why?
| | Infant, Newborn | 14 | 2021 | 5740 | 0.530 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.530 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.530 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 8 | 0.530 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.470 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.470 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 19 | 0.470 |
Why?
| | Mitochondrial Myopathies | 2 | 2023 | 8 | 0.460 |
Why?
| | Disease Models, Animal | 1 | 2024 | 3947 | 0.440 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.440 |
Why?
| | Glutaredoxins | 1 | 2013 | 12 | 0.440 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5281 | 0.440 |
Why?
| | Spasm | 1 | 2013 | 20 | 0.430 |
Why?
| | Genetic Variation | 2 | 2021 | 935 | 0.430 |
Why?
| | Brain | 7 | 2024 | 2624 | 0.420 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 155 | 0.400 |
Why?
| | DNA Mutational Analysis | 8 | 2019 | 385 | 0.400 |
Why?
| | Humans | 47 | 2024 | 128499 | 0.370 |
Why?
| | Metabolic Diseases | 2 | 2010 | 104 | 0.370 |
Why?
| | Channelopathies | 1 | 2011 | 5 | 0.370 |
Why?
| | Amino Acids | 1 | 2015 | 477 | 0.370 |
Why?
| | Liver Diseases | 2 | 2013 | 287 | 0.370 |
Why?
| | Seizures | 3 | 2011 | 400 | 0.360 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 78 | 0.360 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.350 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.350 |
Why?
| | Male | 27 | 2024 | 63045 | 0.340 |
Why?
| | Neurogenesis | 1 | 2011 | 125 | 0.330 |
Why?
| | Ophthalmoplegia, Chronic Progressive External | 1 | 2009 | 3 | 0.320 |
Why?
| | Female | 27 | 2024 | 68268 | 0.320 |
Why?
| | Anticonvulsants | 2 | 2010 | 202 | 0.310 |
Why?
| | Nutrition Therapy | 1 | 2009 | 31 | 0.310 |
Why?
| | Holocarboxylase Synthetase Deficiency | 1 | 2008 | 2 | 0.310 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 2008 | 4 | 0.310 |
Why?
| | Biotin | 1 | 2008 | 23 | 0.310 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1404 | 0.300 |
Why?
| | RNA, Transfer, Glu | 1 | 2007 | 5 | 0.290 |
Why?
| | Proteins | 1 | 2013 | 936 | 0.290 |
Why?
| | DNA Helicases | 1 | 2009 | 149 | 0.280 |
Why?
| | Vitamin B 12 | 2 | 2021 | 122 | 0.280 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1490 | 0.270 |
Why?
| | Oxidative Phosphorylation | 2 | 2021 | 186 | 0.270 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2822 | 0.260 |
Why?
| | GTP Cyclohydrolase | 1 | 2006 | 8 | 0.260 |
Why?
| | Paraparesis, Spastic | 1 | 2006 | 2 | 0.260 |
Why?
| | Child | 15 | 2024 | 20805 | 0.250 |
Why?
| | RNA, Transfer, Asp | 1 | 2005 | 2 | 0.250 |
Why?
| | Fatal Outcome | 3 | 2013 | 301 | 0.250 |
Why?
| | Dystonia | 1 | 2006 | 23 | 0.250 |
Why?
| | Child, Preschool | 11 | 2019 | 10487 | 0.250 |
Why?
| | Parkinsonian Disorders | 1 | 2006 | 36 | 0.250 |
Why?
| | Tremor | 1 | 2006 | 60 | 0.240 |
Why?
| | Biomarkers | 3 | 2024 | 3893 | 0.240 |
Why?
| | Benzoic Acid | 1 | 2005 | 4 | 0.240 |
Why?
| | Polymers | 1 | 2009 | 475 | 0.240 |
Why?
| | Heterozygote | 3 | 2017 | 269 | 0.240 |
Why?
| | Benzoates | 1 | 2005 | 41 | 0.230 |
Why?
| | Fibroblasts | 3 | 2019 | 937 | 0.230 |
Why?
| | Eye | 2 | 2019 | 105 | 0.230 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 2044 | 0.220 |
Why?
| | Brain Diseases | 3 | 2015 | 137 | 0.220 |
Why?
| | Dietary Supplements | 2 | 2020 | 531 | 0.220 |
Why?
| | Hydrocephalus | 2 | 2024 | 108 | 0.220 |
Why?
| | Glucose | 1 | 2009 | 983 | 0.220 |
Why?
| | Genotype | 3 | 2019 | 1830 | 0.210 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2003 | 14 | 0.210 |
Why?
| | Drug Combinations | 1 | 2024 | 324 | 0.210 |
Why?
| | Pedigree | 3 | 2019 | 485 | 0.190 |
Why?
| | Animals, Newborn | 1 | 2024 | 808 | 0.190 |
Why?
| | Point Mutation | 2 | 2017 | 225 | 0.190 |
Why?
| | 2-Aminoadipic Acid | 2 | 2019 | 8 | 0.180 |
Why?
| | Echocardiography | 1 | 2024 | 624 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 157 | 0.180 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 8 | 0.170 |
Why?
| | External Capsule | 1 | 2019 | 2 | 0.170 |
Why?
| | Adolescent | 10 | 2020 | 20304 | 0.170 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 14 | 0.170 |
Why?
| | NADH Dehydrogenase | 1 | 2019 | 18 | 0.170 |
Why?
| | Porencephaly | 1 | 2019 | 6 | 0.160 |
Why?
| | Collagen Type IV | 1 | 2019 | 22 | 0.160 |
Why?
| | Proteomics | 2 | 2024 | 1018 | 0.160 |
Why?
| | Twins, Monozygotic | 1 | 2019 | 209 | 0.150 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 2 | 2021 | 22 | 0.150 |
Why?
| | Spectrum Analysis | 1 | 2019 | 88 | 0.150 |
Why?
| | Lactic Acid | 1 | 2019 | 294 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2019 | 510 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 178 | 0.140 |
Why?
| | Cell Respiration | 2 | 2015 | 98 | 0.140 |
Why?
| | Liver | 3 | 2015 | 1827 | 0.140 |
Why?
| | Acyl-CoA Dehydrogenase | 2 | 2009 | 8 | 0.130 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.130 |
Why?
| | Cataract | 1 | 2019 | 208 | 0.130 |
Why?
| | Gene Expression | 2 | 2015 | 1455 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 30 | 0.120 |
Why?
| | Introns | 1 | 2016 | 250 | 0.120 |
Why?
| | Lysosomal Storage Diseases | 1 | 2015 | 4 | 0.120 |
Why?
| | Diet Therapy | 1 | 2015 | 34 | 0.120 |
Why?
| | Prognosis | 2 | 2015 | 3780 | 0.120 |
Why?
| | COS Cells | 1 | 2015 | 186 | 0.120 |
Why?
| | Mental Retardation, X-Linked | 1 | 2015 | 13 | 0.120 |
Why?
| | Exons | 1 | 2016 | 339 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 30 | 0.120 |
Why?
| | Dyskinesias | 1 | 2015 | 19 | 0.120 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 89 | 0.120 |
Why?
| | Electron Transport | 1 | 2015 | 112 | 0.120 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 340 | 0.110 |
Why?
| | Demyelinating Diseases | 1 | 2015 | 84 | 0.110 |
Why?
| | Base Sequence | 2 | 2010 | 2137 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 87 | 0.110 |
Why?
| | Cell Line | 1 | 2019 | 2741 | 0.110 |
Why?
| | Treatment Outcome | 6 | 2023 | 10162 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 322 | 0.110 |
Why?
| | Genes, X-Linked | 1 | 2013 | 17 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 14 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 3 | 2013 | 2269 | 0.110 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 27 | 0.110 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2013 | 23 | 0.110 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2013 | 2 | 0.110 |
Why?
| | Alleles | 1 | 2016 | 842 | 0.110 |
Why?
| | Genetic Testing | 1 | 2016 | 428 | 0.110 |
Why?
| | Atrophy | 1 | 2013 | 170 | 0.100 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 24 | 0.100 |
Why?
| | Stilbenes | 1 | 2013 | 36 | 0.100 |
Why?
| | Sequence Alignment | 2 | 2015 | 330 | 0.100 |
Why?
| | Liver Transplantation | 1 | 2020 | 800 | 0.100 |
Why?
| | DNA | 1 | 2019 | 1394 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1016 | 0.100 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 23 | 0.090 |
Why?
| | Genetic Association Studies | 2 | 2010 | 361 | 0.090 |
Why?
| | Time | 1 | 2011 | 75 | 0.090 |
Why?
| | Vitamin B 6 | 1 | 2011 | 9 | 0.090 |
Why?
| | Quality of Life | 1 | 2023 | 2688 | 0.090 |
Why?
| | Cystathionine beta-Synthase | 1 | 2011 | 68 | 0.090 |
Why?
| | Age of Onset | 3 | 2013 | 495 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2019 | 14472 | 0.090 |
Why?
| | Adult | 7 | 2021 | 35302 | 0.090 |
Why?
| | Homocystinuria | 1 | 2011 | 69 | 0.090 |
Why?
| | Diffuse Cerebral Sclerosis of Schilder | 1 | 2010 | 4 | 0.090 |
Why?
| | Animals | 4 | 2024 | 34647 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 57 | 0.080 |
Why?
| | Chemokines | 1 | 2011 | 222 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1938 | 0.080 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 190 | 0.080 |
Why?
| | Mice | 3 | 2024 | 16620 | 0.080 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2010 | 44 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 968 | 0.080 |
Why?
| | Biogenic Monoamines | 1 | 2009 | 15 | 0.080 |
Why?
| | Structure-Activity Relationship | 1 | 2010 | 539 | 0.080 |
Why?
| | Leucovorin | 1 | 2009 | 68 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 504 | 0.080 |
Why?
| | Neonatal Screening | 1 | 2010 | 164 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 2011 | 491 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 178 | 0.080 |
Why?
| | Nervous System Diseases | 1 | 2011 | 252 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2009 | 227 | 0.080 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 316 | 0.080 |
Why?
| | Fatty Liver | 1 | 2011 | 231 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5045 | 0.070 |
Why?
| | Protein Conformation | 1 | 2010 | 854 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 259 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1412 | 0.070 |
Why?
| | Reflex, Abnormal | 1 | 2006 | 7 | 0.060 |
Why?
| | Tendinopathy | 1 | 2006 | 22 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2719 | 0.060 |
Why?
| | Phenylalanine | 1 | 2006 | 65 | 0.060 |
Why?
| | Diet | 3 | 2012 | 1204 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1484 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2013 | 4017 | 0.060 |
Why?
| | Sodium Benzoate | 1 | 2005 | 5 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2011 | 4874 | 0.060 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2005 | 18 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1624 | 0.060 |
Why?
| | Consensus | 2 | 2020 | 610 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 336 | 0.060 |
Why?
| | Transferases | 1 | 2005 | 33 | 0.060 |
Why?
| | Psychomotor Disorders | 1 | 2004 | 17 | 0.060 |
Why?
| | Multienzyme Complexes | 1 | 2005 | 68 | 0.060 |
Why?
| | Motor Skills Disorders | 1 | 2005 | 26 | 0.060 |
Why?
| | Physicians | 1 | 2013 | 863 | 0.060 |
Why?
| | Young Adult | 2 | 2011 | 12349 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1262 | 0.060 |
Why?
| | Merozoite Surface Protein 1 | 1 | 2023 | 4 | 0.050 |
Why?
| | Stereoisomerism | 1 | 2003 | 96 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1027 | 0.050 |
Why?
| | Circadian Rhythm | 1 | 2006 | 412 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 245 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 17 | 0.050 |
Why?
| | Lower Extremity | 1 | 2006 | 403 | 0.050 |
Why?
| | Biopsy | 1 | 2005 | 1079 | 0.050 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 40 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 316 | 0.050 |
Why?
| | Homocysteine | 1 | 2021 | 149 | 0.050 |
Why?
| | Pregnancy | 2 | 2011 | 6373 | 0.040 |
Why?
| | Pipecolic Acids | 2 | 2012 | 25 | 0.040 |
Why?
| | Cognition | 2 | 2022 | 1110 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2005 | 732 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 234 | 0.040 |
Why?
| | Colorado | 1 | 2010 | 4399 | 0.040 |
Why?
| | Thymidine | 1 | 2020 | 59 | 0.040 |
Why?
| | International Cooperation | 1 | 2020 | 173 | 0.040 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 26 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2010 | 1624 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 121 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1856 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1698 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 3122 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 8 | 0.030 |
Why?
| | Aminoacylation | 1 | 2015 | 12 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 575 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6506 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 130 | 0.030 |
Why?
| | Exome | 1 | 2015 | 220 | 0.030 |
Why?
| | Neuroglia | 1 | 2015 | 166 | 0.030 |
Why?
| | Delphi Technique | 1 | 2014 | 222 | 0.030 |
Why?
| | Middle Aged | 2 | 2023 | 30923 | 0.030 |
Why?
| | Citrate (si)-Synthase | 1 | 2013 | 58 | 0.030 |
Why?
| | Myelin Sheath | 1 | 2015 | 161 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2013 | 57 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 311 | 0.020 |
Why?
| | North America | 1 | 2013 | 290 | 0.020 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 23 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 573 | 0.020 |
Why?
| | Betaine | 1 | 2011 | 72 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 56 | 0.020 |
Why?
| | Northwestern United States | 1 | 2010 | 55 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 683 | 0.020 |
Why?
| | Southwestern United States | 1 | 2010 | 91 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 107 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 712 | 0.020 |
Why?
| | Patient Care Management | 1 | 2010 | 56 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2010 | 8 | 0.020 |
Why?
| | Public Health Practice | 1 | 2010 | 64 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1244 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 401 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 246 | 0.020 |
Why?
| | Aged | 1 | 2009 | 21976 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 373 | 0.020 |
Why?
| | Family Health | 1 | 2010 | 195 | 0.020 |
Why?
| | Information Dissemination | 1 | 2010 | 204 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 424 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2010 | 196 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 492 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2010 | 663 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 2110 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 715 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1817 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 816 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 456 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1187 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2679 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 2069 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2710 | 0.010 |
Why?
| | Myoclonic Epilepsy, Juvenile | 1 | 2004 | 1 | 0.010 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2004 | 12 | 0.010 |
Why?
| | Nystagmus, Pathologic | 1 | 2004 | 10 | 0.010 |
Why?
| | Apnea | 1 | 2004 | 20 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 2765 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2516 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3021 | 0.010 |
Why?
| | Health Surveys | 1 | 2004 | 493 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1265 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2004 | 604 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 1951 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2604 | 0.010 |
Why?
| | Registries | 1 | 2004 | 1883 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 5371 | 0.010 |
Why?
|
|
Van Hove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|